Literature DB >> 28579724

Cancer Immunotherapy, Part 1: Current Strategies and Agents.

C Lee Ventola.   

Abstract

This article, the first in a series of three, introduces cancer immunology, cancer immunotherapy strategies, and the classes of anticancer therapeutic agents.

Entities:  

Year:  2017        PMID： 28579724      PMCID： PMC5440098     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  10 in total

1.  A new era in cancer immunotherapy: discovering novel targets and reprogramming the immune system.

Authors:  Maurizio Chiriva-Internati; Adrian Bot
Journal:  Int Rev Immunol       Date:  2015-03       Impact factor: 5.311

Review 2.  Current Challenges in Cancer Treatment.

Authors:  Jon Zugazagoitia; Cristiano Guedes; Santiago Ponce; Irene Ferrer; Sonia Molina-Pinelo; Luis Paz-Ares
Journal:  Clin Ther       Date:  2016-05-02       Impact factor: 3.393

Review 3.  Cancer immunology for the clinician.

Authors:  Louis M Weiner
Journal:  Clin Adv Hematol Oncol       Date:  2015-05

Review 4.  Immunotherapy Approaches in Cancer Treatment.

Authors:  Pavel Klener; Pavel Otáhal; Lucie Lateckova; Pavel Klener
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

Review 5.  Cancer and the Immune System: Basic Concepts and Targets for Intervention.

Authors:  Drew Pardoll
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

Review 6.  Cancer immunotherapy: harnessing the immune system to battle cancer.

Authors:  Yiping Yang
Journal:  J Clin Invest       Date:  2015-09-01       Impact factor: 14.808

Review 7.  Cancer immunotherapies, their safety and toxicity.

Authors:  Gheath Alatrash; Haroon Jakher; Patricia D Stafford; Elizabeth A Mittendorf
Journal:  Expert Opin Drug Saf       Date:  2013-05-14       Impact factor: 4.250

Review 8.  Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challenges.

Authors:  Francesca Tartari; Matteo Santoni; Luciano Burattini; Paola Mazzanti; Azzurra Onofri; Rossana Berardi
Journal:  Cancer Treat Rev       Date:  2016-06-07       Impact factor: 12.111

Review 9.  The development of immunotherapy in older adults: New treatments, new toxicities?

Authors:  Carole Helissey; Cécile Vicier; Stéphane Champiat
Journal:  J Geriatr Oncol       Date:  2016-06-16       Impact factor: 3.599

Review 10.  New approaches for cancer immunotherapy.

Authors:  Ayfer Karlitepe; Ozgun Ozalp; Cigir Biray Avci
Journal:  Tumour Biol       Date:  2015-05-02
  10 in total
  27 in total

1.  Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer.

Authors:  Nadina Tinsley; Cong Zhou; Grace Tan; Samuel Rack; Paul Lorigan; Fiona Blackhall; Matthew Krebs; Louise Carter; Fiona Thistlethwaite; Donna Graham; Natalie Cook
Journal:  Oncologist       Date:  2019-07-10

Review 2.  Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes.

Authors:  Bruna Corradetti; Simone Pisano; Robert Steven Conlan; Mauro Ferrari
Journal:  J Pharmacol Exp Ther       Date:  2019-02-08       Impact factor: 4.030

Review 3.  Comparison of DNA and mRNA vaccines against cancer.

Authors:  Zohreh Jahanafrooz; Behzad Baradaran; Jafar Mosafer; Mahmoud Hashemzaei; Tayebeh Rezaei; Ahad Mokhtarzadeh; Michael R Hamblin
Journal:  Drug Discov Today       Date:  2019-12-13       Impact factor: 7.851

4.  Can an amino acid-based oral rehydration solution be effective in managing immune therapy-induced diarrhea?

Authors:  J D Hendrie; A Chauhan; N R Nelson; L B Anthony
Journal:  Med Hypotheses       Date:  2019-03-27       Impact factor: 4.411

Review 5.  Targeting Akt-associated microRNAs for cancer therapeutics.

Authors:  Mir S Adil; Daulat Khulood; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-12-24       Impact factor: 6.100

6.  Gastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved Survival.

Authors:  Mohammad Alomari; Suleiman Al Ashi; Pravallika Chadalavada; Shrouq Khazaaleh; Fahrettin Covut; Laith Al Momani; Ahmed Elkafrawy; Vinay Padbidri; Pauline Funchain; Donald Campbell; Carlos Romero-Marrero
Journal:  Gastroenterology Res       Date:  2022-03-12

Review 7.  Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer.

Authors:  Isabel Ben-Batalla; María Elena Vargas-Delgado; Gunhild von Amsberg; Melanie Janning; Sonja Loges
Journal:  Front Immunol       Date:  2020-07-02       Impact factor: 7.561

Review 8.  Adverse Events of Oncologic Immunotherapy and Their Management.

Authors:  Fedricker Diane Barber
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Jul-Sep

9.  Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis.

Authors:  Itunu Owoyemi; Lisa E Vaughan; Collin M Costello; Charat Thongprayoon; Svetomir N Markovic; Joerg Herrmann; Clark C Otley; Timucin Taner; Aaron R Mangold; Nelson Leung; Sandra M Herrmann; Aleksandra Kukla
Journal:  Cancer       Date:  2020-08-12       Impact factor: 6.860

10.  Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models.

Authors:  Ilenia Iaia; Loretta Gammaitoni; Giulia Cattaneo; Lidia Giraudo; Chiara Donini; Erika Fiorino; Luca Primo; Fabrizio Carnevale-Schianca; Massimo Aglietta; Alberto Puliafito; Dario Sangiolo
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.